Clincosm LogoSign in Get a demo

Anaplastic Astrocytoma

Showing NaN - NaN of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

Recruiting
  • Diffuse Astrocytoma
  • +22 more
  • Phoenix, Arizona
  • +26 more
Jan 27, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
Jan 9, 2023

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • New York, New York
    Lenox Hill Brain Tumor Center
Nov 10, 2022

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

Active, not recruiting
  • Brain Tumor, Recurrent
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • New York, New York
  • +1 more
Jun 9, 2022

Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)

Active, not recruiting
  • Anaplastic Astrocytoma
  • Recurrent Anaplastic Astrocytoma
  • Birmingham, Alabama
  • +78 more
Jan 19, 2022

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States

Completed
Has Results
  • Anaplastic Astrocytoma
  • +3 more
  • 3-Dimensional Conformal Radiation Therapy
  • +3 more
  • Birmingham, Alabama
  • +179 more
Oct 5, 2021

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)

Suspended
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Bevacizumab and Carboplatin
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Super-Selective Intraarterial Intracranial Infusion of

Completed
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Super-Selective Intraarterial Intracranial Infusion of Temozolomide
  • New York, New York
    Lenox Hill Brain Tumor Center
Mar 2, 2021

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Worldwide (Toca 511, Toca FC, Lomustine)

Terminated
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Toca 511
  • +4 more
  • Phoenix, Arizona
  • +66 more
Feb 6, 2020

Genetic Analysis of Brain Tumors

Terminated
  • Glioma
  • +4 more
    • Bethesda, Maryland
    • +2 more
    Dec 6, 2019

    Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)

    Completed
    Has Results
    • Anaplastic Astrocytoma
    • +12 more
    • 3-Dimensional Conformal Radiation Therapy
    • +5 more
    • Los Angeles, California
    • +11 more
    Jul 17, 2019

    Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy

    Withdrawn
    • Glioblastoma Multiforme
    • +2 more
    • MRS Spectroscopy
    • New York, New York
      Weill Cornell Medical College Department of Neurosurgery
    May 30, 2019

    Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II Trial in United States (imetelstat sodium)

    Terminated
    Has Results
    • Anaplastic Astrocytoma
    • +8 more
    • imetelstat sodium
    • Los Angeles, California
    • +10 more
    Jun 20, 2018

    Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating

    Completed
    • Teratoid Tumor, Atypical
    • +9 more
    • azurin-derived cell-penetrating peptide p28
    • Los Angeles, California
    • +10 more
    Aug 3, 2017

    Glioblastoma, Malignant Glioma, Brain Tumors Trial in New York (Stem Cell Radiotherapy (ScRT) and Temozolomide)

    Terminated
    Has Results
    • Glioblastoma
    • +3 more
    • Stem Cell Radiotherapy (ScRT) and Temozolomide
    • New York, New York
      Roosevelt Hospital
    Apr 28, 2017

    Glioblastoma Multiforme (GBM), ANAPLASTIC ASTROCYTOMA (AOA), GBM Trial in New York (Superselective Intraarterial Cerebral

    Completed
    • Glioblastoma Multiforme (GBM)
    • +3 more
    • Superselective Intraarterial Cerebral Infusion of Cetuximab
    • New York, New York
      Lenox Hill Brain Tumor Center
    Jan 30, 2017

    Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Erlotinib)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • New York, New York
      Lenox Hill Brain Tumor Center
    Jan 12, 2016

    Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Super-Selective Intraarterial Intracranial Infusion of

    Completed
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • Super-Selective Intraarterial Intracranial Infusion of BEVACIZUMAB
    • New York, New York
      Lenox Hill Brain Tumor Center
    Apr 20, 2015

    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in United States (IL13-PE38QQR, targeted fusion protein

    Completed
    • Malignant Glioma
    • +4 more
    • San Francisco, California
    • +3 more
    Jun 2, 2011